Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 15, 2017 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Common Stock To Trade On The OTCQB Market

PALATINE, Ill., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that shares of its...
January 03, 2017 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Exploring Strategic Alternatives

PALATINE, Ill., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that it is exploring...
December 14, 2016 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceutical Provides Development Update on its LIMITx(TM) Technology

PALATINE, IL--(Marketwired - December 14, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the U.S. Food...
November 14, 2016 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Third Quarter 2016 Financial Results

PALATINE, IL--(Marketwired - November 14, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
November 09, 2016 10:30 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host Third Quarter 2016 Financial Results Conference Call on November 15, 2016

PALATINE, IL--(Marketwired - November 09, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company...
October 18, 2016 06:30 ET | Source: Acura Pharmaceuticals, Inc.

KemPharm Announces Licensing Agreement with Acura Pharmaceuticals for Aversion(R) Abuse-Deterrent Technology

CORALVILLE, IA and PALATINE, IL --(Marketwired - October 18, 2016) - KemPharm, Inc. (NASDAQ: KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of...
August 08, 2016 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces Second Quarter 2016 Financial Results

PALATINE, IL--(Marketwired - August 08, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for...
July 11, 2016 06:30 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals to Host Webcast on July 14, 2016 to Discuss Additional Data From Study AP-LTX-400

PALATINE, IL--(Marketwired - July 11, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the Company will...
June 08, 2016 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceutical's LIMITX(TM) Technology Successfully Confirms Oral Abuse Deterrence Capabilities

PALATINE, IL--(Marketwired - June 08, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from...
May 02, 2016 16:15 ET | Source: Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals Announces First Quarter 2016 Financial Results

PALATINE, IL--(Marketwired - May 02, 2016) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...